A marginal positive association was observed between the IL-6 level and breast cancer risk when IL-6 levels were categorised into two groups based on the 1.5-pg/mL cut-off value (crude OR = 1.38; 95% CI = 1.00, 1.90). This evidence concerns the gene IL6 and breast cancer.